Foresite Capital Management III’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Foresite Capital Management III’s Portfolio SYRS Stock Details SYRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell
2016 Q3	$832K	Sell
2016 Q2	$2.72M	Buy